Skip to main content

News

Press Release
01/31/2013
TYRX, Inc. announced that it has received a license from Health Canada to market its new AIGISRx R Fully Resorbable Antibacterial Envelope technology with Implantable Electronic Devices (IEDs). The AIGISRx R Antibacterial Envelope is...
TYRX, Inc. announced that it has received a license from Health Canada to market its new AIGISRx R Fully Resorbable Antibacterial Envelope technology with Implantable Electronic Devices (IEDs). The AIGISRx R Antibacterial Envelope is...
TYRX, Inc. announced that it has...
01/31/2013
EP Lab Digest
Press Release
01/30/2013
Company expands evaluation of its EnligHTN renal denervation technology for hypertension to new patient populations St. Jude Medical, Inc., a global medical device company, announced enrollment of the first patient in the EnligHTN II trial....
Company expands evaluation of its EnligHTN renal denervation technology for hypertension to new patient populations St. Jude Medical, Inc., a global medical device company, announced enrollment of the first patient in the EnligHTN II trial....
Company expands evaluation of...
01/30/2013
EP Lab Digest
Press Release
01/29/2013
LeGoo® Proprietary Gel Technology Provides Clear Surgical Field for Cardiothoracic and Vascular Surgeons Without Trauma to Blood Vessels Sanofi US announced the commercial launch of LeGoo®, a biopolymer gel that allows surgeons to...
LeGoo® Proprietary Gel Technology Provides Clear Surgical Field for Cardiothoracic and Vascular Surgeons Without Trauma to Blood Vessels Sanofi US announced the commercial launch of LeGoo®, a biopolymer gel that allows surgeons to...
LeGoo® Proprietary Gel...
01/29/2013
EP Lab Digest
Press Release
01/29/2013
Pledge Made at the Masimo Foundation Patient Safety, Science & Technology Summit Encourages Others Share Health Data to Improve Patient Care ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions,...
Pledge Made at the Masimo Foundation Patient Safety, Science & Technology Summit Encourages Others Share Health Data to Improve Patient Care ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions,...
Pledge Made at the Masimo...
01/29/2013
EP Lab Digest
Press Release
01/28/2013
St. Jude Medical, Inc., a global medical device company, announced European CE Mark approval of its AMPLATZER™ Amulet™ Left Atrial Appendage Occluder. The Amulet device is used to close the left atrial appendage (LAA) in patients diagnosed...
St. Jude Medical, Inc., a global medical device company, announced European CE Mark approval of its AMPLATZER™ Amulet™ Left Atrial Appendage Occluder. The Amulet device is used to close the left atrial appendage (LAA) in patients diagnosed...
St. Jude Medical, Inc., a global...
01/28/2013
EP Lab Digest
Press Release
01/24/2013
2,000-patient study from BIOTRONIK to assess the world’s only single-chamber ICD with complete atrial diagnostics BIOTRONIK, a leading manufacturer of innovative medical technology, announced the start of the large-scale international MATRIX...
2,000-patient study from BIOTRONIK to assess the world’s only single-chamber ICD with complete atrial diagnostics BIOTRONIK, a leading manufacturer of innovative medical technology, announced the start of the large-scale international MATRIX...
2,000-patient study from...
01/24/2013
EP Lab Digest
Press Release
01/24/2013
Innovation Allows Physicians to Direct Epicardial Ablation on Atrium and Create Lesions on Ventricle nContact, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s modifications to its VisiTrax® cardiac...
Innovation Allows Physicians to Direct Epicardial Ablation on Atrium and Create Lesions on Ventricle nContact, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s modifications to its VisiTrax® cardiac...
Innovation Allows Physicians to...
01/24/2013
EP Lab Digest
Press Release
01/24/2013
The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer® Open-Irrigated Temperature Ablation Catheter in patients with symptomatic, drug refractory...
The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer® Open-Irrigated Temperature Ablation Catheter in patients with symptomatic, drug refractory...
The first patient has been...
01/24/2013
EP Lab Digest
Press Release
01/24/2013
The first FDA-cleared mobile device-based ECG monitor now available for purchase allows medical professionals to measure heart rhythm easily, quickly and even remotely. AliveCor’s Heart Monitor, which has been granted FDA 510(k) clearance...
The first FDA-cleared mobile device-based ECG monitor now available for purchase allows medical professionals to measure heart rhythm easily, quickly and even remotely. AliveCor’s Heart Monitor, which has been granted FDA 510(k) clearance...
The first FDA-cleared mobile...
01/24/2013
EP Lab Digest
Press Release
01/18/2013
 Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, will showcase its portfolio of cutting edge innovative technologies at the 2013 Boston AF meeting. Boston AF, now in its 18th year, provides a...
 Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, will showcase its portfolio of cutting edge innovative technologies at the 2013 Boston AF meeting. Boston AF, now in its 18th year, provides a...
 Biosense Webster, Inc., a...
01/18/2013
EP Lab Digest